secwatch.observer — SEC 8-K summary
======================================

Issuer:     ELITE PHARMACEUTICALS INC /NV/ (ELTP)
CIK:        0001053369
Form:       8-K
Filed at:   2026-08-10T21:07:05+00:00
Accession:  0001493152-26-036905
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elite Pharmaceuticals to release Q1 FY2027 results Aug 13; earnings call Aug 14
-------------------------------------------------------------------------------

- Q1 FY2027 (ended June 30, 2026) financial results to be released Thursday, August 13, 2026.
- Conference call Friday, August 14, 2026, 11:30 AM EDT; dial-in 1-800-346-7359 (domestic) or 1-973-528-0008 (international).
- Conference number 98840; general questions due Aug 12, financial questions due Aug 13 via dianne@elitepharma.com.
- Call to cover financial/operating results and provide a general business update; audio replay available at elite.irpass.com.
- Company develops and distributes niche generic oral controlled-release products from Northvale, NJ facility.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1053369/000149315226036905/0001493152-26-036905-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1053369/000149315226036905/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-036905

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer